Navigation Links
Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
Date:10/20/2009

loping ANA598, a non-nucleoside polymerase inhibitor for the treatment of hepatitis C. The Company has also investigated the potential of ANA773, an oral, small-molecule inducer of endogenous interferons that acts via the Toll-like receptor 7, or TLR7, pathway in hepatitis C.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to Anadys' strategy, development programs, and ability to develop novel medicines for the treatment of hepatitis C. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. For example, the results of preclinical and early clinical studies may not be predictive of future results, and Anadys cannot provide any assurances that ANA598 or ANA773 will not have unforeseen safety issues, will have favorable results in ongoing or future clinical trials or will receive regulatory approval. Risk factors that may cause actual results to differ are more fully discussed in Anadys' SEC filings, including Anadys' Form 10-K for the year ended December 31, 2008 and Anadys' Form 10-Q for the quarter ended June 30, 2009. All forward-looking statements are qualified in their entirety by this cautionary statement. Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

SOURCE Anadys Pharmaceuticals, Inc.


'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
6. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
7. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
8. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire-iReach/ -- Academy Leadership, an ... academy graduates, has published a case study ... Leadership Excellence Course . In September and October 2014, ... to Albuquerque , Indianapolis , ... Photo - http://photos.prnewswire.com/prnh/20140828/140814 ...
(Date:8/28/2014)... LONDON , Aug. 28, 2014  A candidate ... The Gambia and Mali ... safety trials of potential vaccines aimed at preventing the disease that ... West Africa . Human trials of ... Health (NIH) and GlaxoSmithKline, are to be accelerated with funding from ...
(Date:8/28/2014)... 28, 2014   Edison Nation Medical , ... worldwide search for product ideas to improve the ... ideas uncovered through the 6-month search ( www.EdisonNationMedical.com/Seniors ... manufacturers and healthcare retailers with whom Edison Nation ... individuals age 65 and older. The ...
Breaking Medicine Technology:Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 3Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 4Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 5Ebola vaccine trials fast-tracked by international consortium 2Ebola vaccine trials fast-tracked by international consortium 3Ebola vaccine trials fast-tracked by international consortium 4Ebola vaccine trials fast-tracked by international consortium 5Ebola vaccine trials fast-tracked by international consortium 6Ebola vaccine trials fast-tracked by international consortium 7Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3
(Date:8/28/2014)... Career Step, an online provider of career-focused education ... to help students and career seekers explore the opportunities ... video details what medical coders and billers do, what ... education requirements for entering this field. , “Medical coding ... people are considering a career in healthcare,” said Jerolyn ...
(Date:8/28/2014)... Sarasota, FL (PRWEB) August 29, 2014 ... company that brings pharmaceutical industry precision to the ... granted zoning approval for its primary location in ... quickly and decisively with a total commitment to ... look forward to creating," says David Wright, President ...
(Date:8/28/2014)... 2014 When David Gergen, President of ... of Mark Brnovich, was asked to publicly support Mr. ... the Attorney General seat in the State of Arizona, ... support of Cardinal Hall of Fame wide receiver Roy ... and Mark Walczak. Green, Kennard and Walczak are members ...
(Date:8/28/2014)... New Energy Works Timberframe plans for ... the country to Log & Timber Home Shows starting ... New Energy Works team will invite the shows’ attendees ... build expertise, project images, and their new 2015 project ... Works’ Mid-West Representative, will present “A fun-fill odyssey: Realizing ...
(Date:8/28/2014)... investment banker arrives at the emergency department with ... drinks alcohol every dayoften at business lunches, and ... he decided to quit drinking and had his ... , It,s a common scenario in emergency rooms ... consumption and develops withdrawal. , Withdrawal is a ...
Breaking Medicine News(10 mins):Health News:Career Step Releases New Video Designed to Help Students Explore the Medical Coding and Billing Field 2Health News:Sarasota County Approves Zoning for Leading Medical Cannabis Firm AltMed 2Health News:Pro Player Health Alliance Back in the Political Arena 2Health News:Pro Player Health Alliance Back in the Political Arena 3Health News:New Energy Works Timberframers Prepares to Exhibit Timber Framing at Autumn Trade Shows 2Health News:New Energy Works Timberframers Prepares to Exhibit Timber Framing at Autumn Trade Shows 3Health News:Real tremors, or drug-seeking patient? New app can tell 2Health News:Real tremors, or drug-seeking patient? New app can tell 3
... should not be done before 39 weeks unless necessary, study ... birth puts newborns at increased risk for serious problems, according ... March of Dimes and colleagues studied the neurological development ... 2000 and 2004. And they found that late preterm babies ...
... 11 PRA International, a leading,Clinical Research Organization, ... City, Mexico. With years of long-standing South ... The region,s existing base of clinical,sites with ... favorably to PRA,s therapeutic focus. The expansion ...
... FAIRFAX, Va., Dec. 11 Nancy Sander, president and ... (AANMA) today urged committee members to preserve patient access ... meeting of the Pulmonary-Allergy Drugs Advisory Committee, Drug Safety ... of the Food and Drug Administration held in Rockville, ...
... When it comes to health insurance quotes , there are ... served in the military, but that doesn,t mean saving money is ... can do to maximize your health insurance dollar: -  Do ... be available to you, be aware that lower premiums generally come ...
... The Procter & Gamble,Company (NYSE: PG ... New York City,beginning at 8:30 a.m. Eastern Time. ... and the Company,s executive management team will,provide a review ... growth opportunities. , ...
... stress expert advises getting a flu shot and other tips to ... ... December 11, 2008 -- During this time of economic uncertainty, increased ... pressures of the holiday season. But top stress expert Claire ...
Cached Medicine News:Health News:Late Preterm Birth Poses Developmental Risks 2Health News:PRA International Expands Operations in Mexico 2Health News:AANMA Provides Commentary to FDA Advisory Committees Reviewing Benefit-Risk Assessment of 12 Hour Bronchodilators 2Health News:How to Save Money on Health Insurance 2Health News:P&G To Share Confidence in Long-Term Strategies and Goals at 2008 Analyst Meeting 2Health News:P&G To Share Confidence in Long-Term Strategies and Goals at 2008 Analyst Meeting 3Health News:P&G To Share Confidence in Long-Term Strategies and Goals at 2008 Analyst Meeting 4Health News:Don't 'Worry Yourself Sick' This Winter 2Health News:Don't 'Worry Yourself Sick' This Winter 3
... Store 200 to 350 Liters of pure ... and Distribution of Purified Water,Millipores compact S.D.S. ... store 200 to 350 liters of purified ... and to maintain consistent purity of stored ...
... 350 Liters of pure water, Complete, Compact ... Purified Water,Millipores compact S.D.S. Storage and Distribution ... 350 liters of purified water produced by ... consistent purity of stored water, provide effective ...
... Millipore has developed a range of ... match specific water quality requirements. Each ... is designed to specifically target contaminants ... HPLC, molecular biology and ICP-MS. The ...
... Millipore has developed a range ... to match specific water quality requirements. ... systems is designed to specifically target ... as HPLC, molecular biology and ICP-MS. ...
Medicine Products: